|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang H, Fan JH and Qiao YL: Epidemiology,
etiology, and prevention of esophageal squamous cell carcinoma in
China. Cancer Biol Med. 14:33–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malhotra GK, Yanala U, Ravipati A, Follet
M, Vijayakumar M and Are C: Global trends in esophageal cancer. J
Surg Oncol. 115:564–579. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arnold M, Soerjomataram I, Ferlay J and
Forman D: Global incidence of oesophageal cancer by histological
subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen J, Kwong DL, Cao T, Hu Q, Zhang L,
Ming X, Chen J, Fu L and Guan X: Esophageal squamous cell carcinoma
(ESCC): Advance in genomics and molecular genetics. Dis Esophagus.
28:84–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsukada Y, Higashi T, Shimada H, Kikuchi Y
and Terahara A: The use of neoadjuvant therapy for resectable
locally advanced thoracic esophageal squamous cell carcinoma in an
analysis of 5016 patients from 305 designated cancer care hospitals
in Japan. Int J Clin Oncol. 23:81–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang L, Ma J, Han Y, Liu J, Zhou W, Hong
L and Fan D: Targeted therapy in esophageal cancer. Expert Rev
Gastroenterol Hepatol. 10:595–604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Katada C, Muto M, Momma K, Arima M, Tajiri
H, Kanamaru C, Ooyanagi H, Endo H, Michida T, Hasuike N, et al:
Clinical outcome after endoscopic mucosal resection for esophageal
squamous cell carcinoma invading the muscularis mucosae-a
multicenter retrospective cohort study. Endoscopy. 39:779–783.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin D, Ma L, Ye T, Pan Y, Shao L, Song Z,
Jiang S, Chen H and Xiang J: Results of neoadjuvant therapy
followed by esophagectomy for patients with locally advanced
thoracic esophageal squamous cell carcinoma. J Thorac Dis.
9:318–326. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fink U, Stein HJ, Bochtler H, Roder JD,
Wilke HJ and Siewert JR: Neoadjuvant therapy for squamous cell
esophageal carcinoma. Ann Oncol. 5 (Suppl 3):S17–S26. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heise JW, Heep H, Frieling T, Sarbia M,
Hartmann KA and Röher HD: Expense and benefit of neoadjuvant
treatment in squamous cell carcinoma of the esophagus. BMC Cancer.
1:202001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu SY, Liu Z, Ma WJ, Sheyhidin I, Zheng ST
and Lu XM: New potential biomarkers in the diagnosis of esophageal
squamous cell carcinoma. Biomarkers. 14:340–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lo YM, Tein MS, Lau TK, Haines CJ, Leung
TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM and Hjelm NM:
Quantitative analysis of fetal DNA in maternal plasma and serum:
Implications for noninvasive prenatal diagnosis. Am J Hum Genet.
62:768–775. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thrasher AJ and Burns SO: WASP: A key
immunological multitasker. Nat Rev Immunol. 10:182–192. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takenawa T and Suetsugu S: The WASP-WAVE
protein network: Connecting the membrane to the cytoskeleton. Nat
Rev Mol Cell Biol. 8:37–48. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Machesky LM and Insall RH: Scar1 and the
related Wiskott-Aldrich syndrome protein, WASP, regulate the actin
cytoskeleton through the Arp2/3 complex. Curr Biol. 8:1347–1356.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Imai K, Morio T, Zhu Y, Jin Y, Itoh S,
Kajiwara M, Yata J, Mizutani S, Ochs HD and Nonoyama S: Clinical
course of patients with WASP gene mutations. Blood. 103:456–464.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miki H, Suetsugu S and Takenawa T: WAVE, a
novel WASP-family protein involved in actin reorganization induced
by Rac. EMBO J. 17:6932–6941. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sossey-Alaoui K, Ranalli TA, Li X, Bakin
AV and Cowell JK: WAVE3 promotes cell motility and invasion through
the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res.
308:135–145. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sossey-Alaoui K, Li X, Ranalli TA and
Cowell JK: WAVE3-mediated cell migration and lamellipodia formation
are regulated downstream of phosphatidylinositol 3-kinase. J Biol
Chem. 280:21748–21755. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu Z, Chen W, Yin X, Lai J, Wang Q, Liang
L, Wang W, Wang A and Zheng C: WAVE3 induces EMT and promotes
migration and invasion in intrahepatic cholangiocarcinoma. Dig Dis
Sci. 61:1950–1960. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ji Y, Li B, Zhu Z, Guo X, He W, Fan Z and
Zhang W: Overexpression of WAVE3 promotes tumor invasiveness and
confers an unfavorable prognosis in human hepatocellular carcinoma.
Biomed Pharmacother. 69:409–415. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Davuluri G, Sossey-Alaoui K and Plow E:
Abstract 2702: WAVE3 regulates NF B signaling and sensitizes cancer
cells to apoptosis and cell death driven by TNF. Cancer Res. 73
(Suppl 8):27022013.
|
|
24
|
Davuluri G, Augoff K, Schiemann WP, Plow
EF and Sossey-Alaoui K: WAVE3-NFκB interplay is essential for the
survival and invasion of cancer cells. PLoS One. 9:e1106272014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang S, Huang C, Chen W, Liu Y, Yin X,
Lai J, Liang L, Wang Q, Wang A and Zheng C: WAVE3 promotes
proliferation, migration and invasion via the AKT pathway in
pancreatic cancer. Int J Oncol. 53:672–684. 2018.PubMed/NCBI
|
|
26
|
Jaganathan S, Yue P, Paladino DC,
Bogdanovic J, Huo Q and Turkson J: A functional nuclear epidermal
growth factor receptor, SRC and Stat3 heteromeric complex in
pancreatic cancer cells. PLoS One. 6:e196052011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kulkarni S, Augoff K, Rivera L, McCue B,
Khoury T, Groman A, Zhang L, Tian L and Sossey-Alaoui K: Increased
expression levels of WAVE3 are associated with the progression and
metastasis of triple negative breast cancer. PLoS One.
7:e428952012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sossey-Alaoui K, Safina A, Li X, Vaughan
MM, Hicks DG, Bakin AV and Cowell JK: Down-regulation of WAVE3, a
metastasis promoter gene, inhibits invasion and metastasis of
breast cancer cells. Am J Pathol. 170:2112–2121. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moazzam M, Ye L, Sun PH, Kynaston H and
Jiang WG: Knockdown of WAVE3 impairs HGF induced migration and
invasion of prostate cancer cells. Cancer Cell Int. 15:512015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Paterson EL, Kazenwadel J, Bert AG,
Khew-Goodall Y, Ruszkiewicz A and Goodall GJ: Down-regulation of
the miRNA-200 family at the invasive front of colorectal cancers
with degraded basement membrane indicates EMT is involved in cancer
progression. Neoplasia. 15:180–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sossey-Alaoui K, Bialkowska K and Plow EF:
The miR200 family of microRNAs regulates WAVE3-dependent cancer
cell invasion. J Biol Chem. 284:33019–33029. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Honor H, Ackland ML, Blick T, Lawrence MG,
Clements JA, Williams ED and Thompson EW: Epithelial-mesenchymal
and mesenchymal-epithelial transitions in carcinoma progression. J
Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Taylor MA, Davuluri G, Parvani JG,
Schiemann BJ, Wendt MK, Plow EF, Schiemann WP and Sossey-Alaoui K:
Upregulated WAVE3 expression is essential for TGF-β-mediated EMT
and metastasis of triple-negative breast cancer cells. Breast
Cancer Res Treat. 142:341–353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yue Z, Feng W, Xiangke L, Liuxing W,
Qingxia F and Jianbo G: WAVE3 promotes epithelial-mesenchymal
transition of gastric cancer through upregulation of Snail. Cancer
Gene Ther. 21:499–506. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Savagner P: Leaving the neighborhood:
Molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Sun Y, Chen L, Xu X, Zhang X, Wang
B, Min L and Liu W: miRNA-200c increases the sensitivity of breast
cancer cells to doxorubicin through the suppression of
E-cadherin-mediated PTEN/Akt signaling. Mol Med Rep. 7:1579–1584.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cowherd SM: Tumor staging and grading: A
primer. Methods Mol Biol. 823:1–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lu J, Wang SL, Wang YC, Wu YN, Yu X, Zhao
WZ and Wang JH: High WAVE3 expression correlates with
proliferation, migration and invasion in human ovarian cancer.
Oncotarget. 8:41189–41201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jin H, Xie Q, Guo X, Xu J, Wang A, Li J,
Zhu J, Wu XR, Huang H and Huang C: p63α protein up-regulates heat
shock protein 70 expression via E2F1 transcription factor 1,
promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion. J
Biol Chem. 292:15952–15962. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sossey-Alaoui K, Li X and Cowell JK:
c-Abl-mediated phosphorylation of WAVE3 is required for
lamellipodia formation and cell migration. J Biol Chem.
282:26257–26265. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sossey-Alaoui K: Surfing the big WAVE:
Insights into the role of WAVE3 as a driving force in cancer
progression and metastasis. Semin Cell Dev Biol. 24:287–297.
2013.PubMed/NCBI
|
|
46
|
Fernando HS, Sanders AJ, Kynaston HG and
Jiang WG: WAVE3 is associated with invasiveness in prostate cancer
cells. Urol Oncol. 28:320–327. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Condeelis J and Segall JE: Intravital
imaging of cell movement in tumours. Nat Rev Cancer. 3:921–930.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Takenawa T and Miki H: WASP and WAVE
family proteins: Key molecules for rapid rearrangement of cortical
actin filaments and cell movement. J Cell Sci. 114:1801–1809.
2001.PubMed/NCBI
|
